Late breaking news from Asia Pacific

This PVI 2025 session brings a unique, in-depth look at how vascular care is approached across the Asia-Pacific region, offering insights into both clinical and regulatory frameworks that shape treatment decisions. 

The session covers a range of topics, from the research regulations in New Zealand and the management of DVT in Singapore, to CFA treatment strategies in Japan and the handling of acute lower limb ischemia in Malaysia. 

A focus on pulmonary embolism endovascular repair in India highlights innovative practices, while real-world data on the Ranger DCB in CLTI patients provide tangible insights into treatment outcomes. The session also explores aortic dissection management in China, showcasing the journey from traditional open surgery to cutting-edge endovascular solutions.

Throughout, speakers emphasise how regional differences, available resources, and local expertise directly influence decision-making, providing a comprehensive view of vascular care in the Asia-Pacific.

From New Zealand to China, follow how vascular care evolves across Asia-Pacific.